4321 - 4330 of 6422 Results
Title
Year
- Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysis2025OPENTitle: Classification of GBA1 variants and their impact on Parkinson’s disease: an in silico score analysisJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01060-6Best OA location URL: https://www.nature.com/articles/s41531-025-01060-6.pdfCitation Count: 0
-
OPENTitle: Barriers and Facilitators to Accessing Healthcare for People With Parkinson's Disease in Latin America: A Qualitative StudyJournal Name: Health ExpectationsPublisher: WileyVol: 28Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/hex.70380Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/hex.70380Citation Count: 0
-
OPENTitle: Standardised TruAI Automated Quantification of Intracellular Neuromelanin Granules in Human Brain Tissue SectionsJournal Name: Neuropathology and Applied NeurobiologyPublisher: WileyVol: 51Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/nan.70033Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/nan.70033Citation Count: 0
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy2021OPENTitle: Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant EpilepsyJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 110Issue #: 5Start Page: 1368End Page: 1380Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/cpt.2408Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/cpt.2408Citation Count: 31
-
OPENTitle: Antiepileptogenesis and disease modification: Clinical and regulatory issuesJournal Name: Epilepsia OpenPublisher: WileyVol: 6Issue #: 3Start Page: 483End Page: 492Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12526Best OA location URL: https://doi.org/10.1002/epi4.12526Citation Count: 30
-
OPENTitle: Neurological outcome and quality of life 3 months after COVID‐19: A prospective observational cohort studyJournal Name: European Journal of NeurologyPublisher: WileyVol: 28Issue #: 10Start Page: 3348End Page: 3359Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/ene.14803Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14803Citation Count: 169
-
OPENTitle: Transitioning to telegenetics in the COVID‐19 era: Patient satisfaction with remote genetic counseling in adult neurologyJournal Name: Journal of Genetic CounselingPublisher: WileyVol: 30Issue #: 4Start Page: 974End Page: 983Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jgc4.1470Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jgc4.1470Citation Count: 24
-
OPENTitle: Cerebello‐Cortical Control of Tremor Rhythm and Amplitude in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1727End Page: 1729Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28603Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28603Citation Count: 34
-
OPENTitle: Application of the Updated Movement Disorder Society Criteria for Prodromal Parkinson's Disease to a Population‐Based 10‐Year StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 6Start Page: 1464End Page: 1466Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28570Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28570Citation Count: 15
-
OPENTitle: Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1733End Page: 1733Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28659Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28659Citation Count: 1